• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖乳腺癌患者循环长链非编码RNA的抑制

Suppression of circulating long non-coding RNA in obese patients with breast cancer.

作者信息

Choudhry Hani, Hassan Mohammed A, Al-Malki Abdulrahman L, Al-Sakkaf Kaltoom A

机构信息

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.

Cancer and Mutagenesis Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.

出版信息

Oncol Lett. 2021 Jul;22(1):508. doi: 10.3892/ol.2021.12769. Epub 2021 May 3.

DOI:10.3892/ol.2021.12769
PMID:33986869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8114468/
Abstract

Long non-coding RNAs (lncRNAs), a type of cellular RNA, play a critical regulatory role in several physiological developments and pathological processes, such as tumorigenesis and tumor progression. Obesity is a risk factor for a number of serious health conditions, including breast cancer (BC). However, the underlying mechanisms behind the association between obesity and increased BC incidence and mortality remain unclear. Several studies have reported changes in lncRNA expression due to obesity and BC, independently encouraging further investigation of the relationship between the two in connection with lncRNAs. The present study was designed to first screen for the expression of 29 selected lncRNAs that showed a link to cancer or obesity in the blood of a selected cohort of 6 obese and 6 non-obese patients with BC. The expression levels of significantly expressed lncRNAs, and , were further investigated in a larger cohort of 69 patients with BC (36 obese and 33 non-obese), using reverse transcription-quantitative polymerase chain reaction. Results showed not only that remained significantly downregulated in the larger cohort (P=0.002), but also that it was associated with several clinicopathological characteristics, such as negative HER2 status, negative E-cadherin expression, negative vascular invasion, negative margin invasion and LCIS. These findings suggest that obesity may have a role in inhibiting expression, which may serve as a novel potential biomarker and therapeutic target for BC.

摘要

长链非编码RNA(lncRNAs)是一种细胞RNA,在多种生理发育和病理过程中发挥关键调节作用,如肿瘤发生和肿瘤进展。肥胖是包括乳腺癌(BC)在内的多种严重健康问题的危险因素。然而,肥胖与BC发病率和死亡率增加之间关联的潜在机制仍不清楚。几项研究报告了由于肥胖和BC导致的lncRNA表达变化,这独立地鼓励进一步研究两者与lncRNAs之间的关系。本研究旨在首先筛选29种选定的lncRNAs在6名肥胖和6名非肥胖BC患者的选定队列血液中的表达,这些lncRNAs与癌症或肥胖有关。使用逆转录定量聚合酶链反应在69名BC患者(36名肥胖和33名非肥胖)的更大队列中进一步研究显著表达的lncRNAs 和 的表达水平。结果不仅显示 在更大队列中仍显著下调(P = 0.002),而且它与几种临床病理特征相关,如HER2状态阴性、E-钙黏蛋白表达阴性、血管侵犯阴性、切缘侵犯阴性和小叶原位癌。这些发现表明,肥胖可能在抑制 表达中起作用,这可能作为BC的一种新的潜在生物标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/bd04dba8d34e/ol-22-01-12769-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/ac70b77afc8d/ol-22-01-12769-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/7be8ef255ff1/ol-22-01-12769-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/8a1e009548fc/ol-22-01-12769-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/4e68b2836559/ol-22-01-12769-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/bd04dba8d34e/ol-22-01-12769-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/ac70b77afc8d/ol-22-01-12769-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/7be8ef255ff1/ol-22-01-12769-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/8a1e009548fc/ol-22-01-12769-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/4e68b2836559/ol-22-01-12769-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/8114468/bd04dba8d34e/ol-22-01-12769-g04.jpg

相似文献

1
Suppression of circulating long non-coding RNA in obese patients with breast cancer.肥胖乳腺癌患者循环长链非编码RNA的抑制
Oncol Lett. 2021 Jul;22(1):508. doi: 10.3892/ol.2021.12769. Epub 2021 May 3.
2
Differentially expressed circulating LncRNAs and mRNA identified by microarray analysis in obese patients.通过微阵列分析在肥胖患者中鉴定出的差异表达的循环长链非编码RNA和信使核糖核酸
Sci Rep. 2016 Oct 21;6:35421. doi: 10.1038/srep35421.
3
Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.阿霉素相关lncRNA-mRNA网络的综合分析确定了与化疗耐药相关的lnc-TRDMT1-5作为乳腺癌进展的生物标志物。
Front Genet. 2020 May 29;11:566. doi: 10.3389/fgene.2020.00566. eCollection 2020.
4
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
5
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling.乳腺癌中的长链非编码RNA(lncRNA)转录图谱确定LINC01614是受转化生长因子β(TGFβ)和粘着斑激酶(FAK)信号调控的不良预后生物标志物。
Cell Death Discov. 2019 Jun 24;5:109. doi: 10.1038/s41420-019-0190-6. eCollection 2019.
6
Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.用于不同膀胱癌分级特征描述的长链非编码RNA表达谱
Cell Physiol Biochem. 2018;50(3):1154-1163. doi: 10.1159/000494542. Epub 2018 Oct 24.
7
Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.乳腺癌相关 GAS5 和 LSINCT5 lncRNAs 在无癌乳腺组织中的表达水平:与初潮年龄和肥胖的分子关联。
Breast J. 2018 Nov;24(6):876-882. doi: 10.1111/tbj.13067. Epub 2018 May 21.
8
Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.长链非编码RNA MALAT1在乳腺癌组织和血清中的表达的临床意义
Ann Clin Lab Sci. 2016 Jul;46(4):418-24.
9
Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.长链非编码RNA BRAF调控的lncRNA 1促进乳腺癌的淋巴结侵袭、转移和增殖,并预示不良预后。
Oncol Lett. 2018 Jun;15(6):9543-9552. doi: 10.3892/ol.2018.8513. Epub 2018 Apr 17.
10
Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p.长链非编码RNA TTN-AS1通过吸附miR-140-5p促进乳腺癌细胞的迁移和侵袭。
Oncol Lett. 2020 Feb;19(2):1255-1260. doi: 10.3892/ol.2019.11222. Epub 2019 Dec 17.

引用本文的文献

1
Changes in Circulating Levels of Long Non-Coding RNA p5549 and p19461 Following Metabolic Bariatric Surgery (MBS): A Prospective Study.代谢性减肥手术后循环中长链非编码RNA p5549和p19461水平的变化:一项前瞻性研究
Obes Surg. 2025 Jan;35(1):131-140. doi: 10.1007/s11695-024-07596-5. Epub 2024 Dec 9.
2
Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.疱疹病毒进入介体作为免疫检查点靶点及髓系和淋巴系白血病的潜在预后生物标志物。
Biomolecules. 2024 Apr 27;14(5):523. doi: 10.3390/biom14050523.
3
Epigenetic modifications in obesity-associated diseases.

本文引用的文献

1
The expression profile and role of non-coding RNAs in obesity.非编码 RNA 在肥胖中的表达谱及作用。
Eur J Pharmacol. 2021 Feb 5;892:173809. doi: 10.1016/j.ejphar.2020.173809. Epub 2020 Dec 17.
2
M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2.M2 巨噬细胞诱导的长链非编码 RNA PCAT6 通过调节 VEGFR2 促进三阴性乳腺癌的发生发展和血管生成。
Cell Death Dis. 2020 Sep 9;11(9):728. doi: 10.1038/s41419-020-02926-8.
3
Long non-coding RNA expression in non-obese women with polycystic ovary syndrome and weight-matched controls.
肥胖相关疾病中的表观遗传修饰。
MedComm (2020). 2024 Feb 24;5(2):e496. doi: 10.1002/mco2.496. eCollection 2024 Feb.
4
Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4.与传统细胞毒性T淋巴细胞相关抗原4相比,疱疹病毒进入介质作为乳腺癌潜在生物标志物的研究
Biomed Rep. 2023 Jul 17;19(2):56. doi: 10.3892/br.2023.1638. eCollection 2023 Aug.
非肥胖多囊卵巢综合征女性与体重匹配对照者的长非编码 RNA 表达。
Reprod Biomed Online. 2020 Oct;41(4):579-583. doi: 10.1016/j.rbmo.2020.06.018. Epub 2020 Jul 3.
4
The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.长链非编码 RNA-MALAT1 在乳腺癌患者中的表达及其对预后的影响。
Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):72-78.
5
Integration of Transcriptome and Metabolome Provides Unique Insights to Pathways Associated With Obese Breast Cancer Patients.转录组和代谢组的整合为肥胖乳腺癌患者相关通路提供了独特见解。
Front Oncol. 2020 May 19;10:804. doi: 10.3389/fonc.2020.00804. eCollection 2020.
6
LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.长链非编码 RNA BCRT1 通过靶向 miR-1303/PTBP3 轴促进乳腺癌进展。
Mol Cancer. 2020 May 8;19(1):85. doi: 10.1186/s12943-020-01206-5.
7
FABP4: A New Player in Obesity-Associated Breast Cancer.脂肪细胞型脂肪酸结合蛋白 4:肥胖相关乳腺癌的新角色。
Trends Mol Med. 2020 May;26(5):437-440. doi: 10.1016/j.molmed.2020.03.004. Epub 2020 Apr 8.
8
Expression analysis of vimentin and the related lncRNA network in breast cancer.在乳腺癌中波形蛋白和相关 lncRNA 网络的表达分析。
Exp Mol Pathol. 2020 Aug;115:104439. doi: 10.1016/j.yexmp.2020.104439. Epub 2020 Apr 10.
9
LncSpA: LncRNA Spatial Atlas of Expression across Normal and Cancer Tissues.LncSpA:正常组织和癌症组织中表达的长非编码 RNA 空间图谱。
Cancer Res. 2020 May 15;80(10):2067-2071. doi: 10.1158/0008-5472.CAN-19-2687. Epub 2020 Mar 19.
10
LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases.LncTarD:一个经实验验证的人类疾病中功能性 lncRNA 靶调控的人工 curated 数据库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D118-D126. doi: 10.1093/nar/gkz985.